Ocrelizumab efficacy in subgroups of patients with relapsing multiple sclerosisBenjamin Turner, Stephen L. Hauser, Bruce Cree et al.|Journal of Neurology|2019Cited by 84
Visual Outcomes Following Plasma Exchange for Optic Neuritis: An International Multicenter Retrospective Analysis of 395 Optic Neuritis AttacksJohn J. Chen, Romain Marignier, Sepideh Jamali et al.|American Journal of Ophthalmology|2023Cited by 64
Periventricular remyelination failure in multiple sclerosis: a substrate for neurodegenerationMattéo Tonietto, Bruno Stankoff, Émilie Poirion et al.|Brain|2022Cited by 61
The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021Carmen Tur, Bruno Stankoff, Anne‐Laure Dubessy et al.|Multiple Sclerosis Journal|2022Cited by 46